SLC25A39

gene
On this page

Also known as FLJ22407CGI-69

Summary

SLC25A39 (solute carrier family 25 member 39, HGNC:24279) is a protein-coding gene on chromosome 17q21.31, encoding Mitochondrial glutathione transporter SLC25A39 (Q9BZJ4). Mitochondrial transporter required for glutathione import into mitochondria.

This gene encodes a member of the SLC25 transporter or mitochondrial carrier family of proteins. Members of this family are encoded by the nuclear genome while their protein products are usually embedded in the inner mitochondrial membrane and exhibit wide-ranging substrate specificity. Although the encoded protein is currently considered an orphan transporter, this protein is related to other carriers known to transport amino acids. This protein may play a role in iron homeostasis.

Source: NCBI Gene 51629 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 104 total
  • MANE Select transcript: NM_001143780

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24279
Approved symbolSLC25A39
Namesolute carrier family 25 member 39
Location17q21.31
Locus typegene with protein product
StatusApproved
AliasesFLJ22407, CGI-69
Ensembl geneENSG00000013306
Ensembl biotypeprotein_coding
OMIM610820
Entrez51629

Gene structure

Transcript identifiers

Ensembl transcripts: 53 — 47 protein_coding, 5 retained_intron, 1 nonsense_mediated_decay

ENST00000225308, ENST00000377095, ENST00000537904, ENST00000585523, ENST00000585636, ENST00000585695, ENST00000586016, ENST00000586633, ENST00000588049, ENST00000588315, ENST00000588767, ENST00000590194, ENST00000591006, ENST00000591151, ENST00000592372, ENST00000592857, ENST00000593166, ENST00000903240, ENST00000903241, ENST00000903242, ENST00000903243, ENST00000903244, ENST00000903245, ENST00000903246, ENST00000903247, ENST00000903248, ENST00000903249, ENST00000903250, ENST00000903251, ENST00000903252, ENST00000903253, ENST00000903254, ENST00000903255, ENST00000903256, ENST00000903257, ENST00000903258, ENST00000903259, ENST00000903260, ENST00000903261, ENST00000903262, ENST00000903263, ENST00000903264, ENST00000903265, ENST00000903266, ENST00000903267, ENST00000903268, ENST00000926094, ENST00000926095, ENST00000926096, ENST00000926097, ENST00000926098, ENST00000955435, ENST00000955436

RefSeq mRNA: 5 — MANE Select: NM_001143780 NM_001143780, NM_001321240, NM_001321241, NM_001366726, NM_016016

CCDS: CCDS11482, CCDS45700, CCDS82138

Canonical transcript exons

ENST00000377095 — 12 exons

ExonStartEnd
ENSE000003906644432105844321231
ENSE000028857464432471144324823
ENSE000028892294431962844320116
ENSE000034974924432019644320276
ENSE000035360004432062244320731
ENSE000035442444432328444323343
ENSE000035565574432170044321767
ENSE000036012214432347844323577
ENSE000036066294432241944322552
ENSE000036171764432035544320436
ENSE000036815804432280844322852
ENSE000037847724432143444321558

Expression profiles

Bgee: expression breadth ubiquitous, 246 present calls, max score 98.79.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 153.1663 / max 8318.9075, expressed in 1825 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
166362150.99841825
1663601.5927784
1663610.5751270

Top tissues by expression

254 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
lower esophagus mucosaUBERON:003583498.79gold quality
bloodUBERON:000017898.73gold quality
mucosa of transverse colonUBERON:000499198.52gold quality
metanephros cortexUBERON:001053398.45gold quality
right lobe of thyroid glandUBERON:000111997.94gold quality
adenohypophysisUBERON:000219697.93gold quality
right testisUBERON:000453497.89gold quality
right adrenal glandUBERON:000123397.81gold quality
left lobe of thyroid glandUBERON:000112097.80gold quality
right adrenal gland cortexUBERON:003582797.79gold quality
body of pancreasUBERON:000115097.78gold quality
left adrenal gland cortexUBERON:003582597.76gold quality
left adrenal glandUBERON:000123497.73gold quality
left testisUBERON:000453397.67gold quality
esophagus mucosaUBERON:000246997.51gold quality
cortex of kidneyUBERON:000122597.50gold quality
ileal mucosaUBERON:000033197.34gold quality
right lobe of liverUBERON:000111497.32gold quality
body of stomachUBERON:000116197.21gold quality
transverse colonUBERON:000115797.19gold quality
bone marrowUBERON:000237197.17gold quality
skin of abdomenUBERON:000141697.15gold quality
skin of legUBERON:000151197.11gold quality
bone marrow cellCL:000209297.04gold quality
minor salivary glandUBERON:000183096.97gold quality
adrenal cortexUBERON:000123596.93gold quality
adult mammalian kidneyUBERON:000008296.84gold quality
adrenal glandUBERON:000236996.71gold quality
esophagusUBERON:000104396.68gold quality
thyroid glandUBERON:000204696.65gold quality

Single-cell (SCXA)

Detected in 20 experiment(s), a significant marker in 19.

ExperimentMarker?Max mean expression
E-CURD-122yes1282.14
E-CURD-120yes1123.09
E-MTAB-9221yes838.14
E-MTAB-6653yes694.13
E-GEOD-139324yes486.69
E-MTAB-8207yes436.42
E-HCAD-8yes405.31
E-HCAD-36yes360.86
E-MTAB-10553yes301.57
E-MTAB-10287yes277.51
E-HCAD-4yes147.57
E-CURD-112yes65.96
E-MTAB-10042yes43.65
E-HCAD-9yes13.55
E-MTAB-9467yes10.21

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

21 targeting SLC25A39, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-124-3P99.8973.743043
HSA-MIR-506-3P99.8973.553057
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-6785-5P99.8268.684428
HSA-MIR-149-3P99.7268.223963
HSA-MIR-6883-5P99.6968.053785
HSA-MIR-320299.6667.702737
HSA-MIR-426199.5970.303415
HSA-MIR-3120-3P99.5470.282669
HSA-MIR-5584-5P99.4968.222814
HSA-MIR-6731-5P99.2867.422375
HSA-MIR-808599.2867.562362
HSA-MIR-133A-3P99.2771.531270
HSA-MIR-133B99.2771.531270
HSA-MIR-7160-5P99.1167.172207
HSA-MIR-425499.1165.151315
HSA-MIR-770299.0665.95698
HSA-MIR-3619-5P99.0068.872308
HSA-MIR-214-3P98.7168.122128
HSA-MIR-76198.7168.072051
HSA-MIR-55595.9265.25564

Literature-anchored findings (GeneRIF, showing 7)

  • Required for functional heme biosynthesis in erythroid cells. Possibly regulate ALAS2 through iron-sulfur cluster biogenesis. (PMID:19656490)
  • Compares and contrasts all the known human SLC25A* genes and includes functional information. (PMID:23266187)
  • Germinal GLT8D1, GATAD2A and SLC25A39 mutations in a patient with a glomangiopericytal tumor and five different sarcomas over a 10-year period. (PMID:33963205)
  • SLC25A39 is necessary for mitochondrial glutathione import in mammalian cells. (PMID:34707288)
  • Autoregulatory control of mitochondrial glutathione homeostasis. (PMID:37917749)
  • Dual regulation of SLC25A39 by AFG3L2 and iron controls mitochondrial glutathione homeostasis. (PMID:38157846)
  • SLC25A39 links mitochondrial GSH sensing with iron metabolism. (PMID:38364779)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusSlc25a39ENSMUSG00000018677
rattus_norvegicusSlc25a39ENSRNOG00000020994

Paralogs (49): SLC25A13 (ENSG00000004864), SLC25A5 (ENSG00000005022), SLC25A40 (ENSG00000075303), SLC25A3 (ENSG00000075415), SLC25A43 (ENSG00000077713), SLC25A24 (ENSG00000085491), SLC25A1 (ENSG00000100075), SLC25A17 (ENSG00000100372), SLC25A14 (ENSG00000102078), SLC25A15 (ENSG00000102743), SLC25A11 (ENSG00000108528), UCP1 (ENSG00000109424), SLC25A36 (ENSG00000114120), SLC25A12 (ENSG00000115840), SLC25A2 (ENSG00000120329), SLC25A51 (ENSG00000122696), SLC25A16 (ENSG00000122912), SLC25A35 (ENSG00000125434), SLC25A19 (ENSG00000125454), SLC25A23 (ENSG00000125648), SLC25A47 (ENSG00000140107), SLC25A52 (ENSG00000141437), SLC25A38 (ENSG00000144659), SLC25A26 (ENSG00000144741), SLC25A48 (ENSG00000145832), SLC25A37 (ENSG00000147454), SLC25A25 (ENSG00000148339), SLC25A31 (ENSG00000151475), SLC25A4 (ENSG00000151729), SLC25A27 (ENSG00000153291), SLC25A28 (ENSG00000155287), SLC25A44 (ENSG00000160785), SLC25A45 (ENSG00000162241), SLC25A34 (ENSG00000162461), SLC25A32 (ENSG00000164933), SLC25A6 (ENSG00000169100), SLC25A33 (ENSG00000171612), SLC25A30 (ENSG00000174032), UCP3 (ENSG00000175564), UCP2 (ENSG00000175567)

Protein

Protein identifiers

Mitochondrial glutathione transporter SLC25A39Q9BZJ4 (reviewed: Q9BZJ4)

Alternative names: Solute carrier family 25 member 39

All UniProt accessions (10): Q9BZJ4, B4DFG5, K7EJI2, K7EKC2, K7EKF4, K7ELM7, K7EMR4, K7EMW3, K7EQS4, K7EQS8

UniProt curated annotations — full annotation on UniProt →

Function. Mitochondrial transporter required for glutathione import into mitochondria. Glutathione, which plays key roles in oxidative metabolism, is produced exclusively in the cytosol and is imported in many organelles. Mitochondrial glutathione is required for the activity and stability of proteins containing iron-sulfur clusters, as well as erythropoiesis.

Subcellular location. Mitochondrion inner membrane.

Tissue specificity. Expressed in many tissues. Abundant in testis and kidney.

Post-translational modifications. Cleaved and degraded by AFG3L2; degradation by AFG3L2 is regulated by the ability of SLC25A39 to bind iron-sulfur. In absence of mitochondrial glutathione, SLC25A39 binds iron-sulfur, preventing cleavage and degradation by AFG3L2. The presence of mitochondrial glutathione prevents iron-sulfur-binding to SLC25A39, promoting cleavage and degradation by AFG3L2.

Activity regulation. The activity of SLC25A39 is regulated by levels of mitochondrial glutathione via its ability to bind [2Fe-2S] iron-sulfur cluster. Upon physiological levels of mitochondrial glutathione, glutathione prevents iron-sulfur-binding to SLC25A39 promoting cleavage and degradation by AFG3L2. Upon depletion of mitochondrial glutathione, SLC25A39 binds iron-sulfur, preventing cleavage and degradation by AFG3L2.

Similarity. Belongs to the mitochondrial carrier (TC 2.A.29) family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9BZJ4-11, CGI-69Lyes
Q9BZJ4-22

RefSeq proteins (5): NP_001137252, NP_001308169, NP_001308170, NP_001353655, NP_057100 (=MANE)

Domains & families (InterPro)

IDNameType
IPR018108MCP_transmembraneRepeat
IPR023395MCP_dom_sfHomologous_superfamily
IPR045315Mtm1-likeFamily

Pfam: PF00153

Catalyzed reactions (Rhea), 1 shown:

  • glutathione(in) = glutathione(out) (RHEA:74819)

UniProt features (27 total): topological domain 7, transmembrane region 6, binding site 4, repeat 3, mutagenesis site 3, chain 1, splice variant 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BZJ4-F173.840.25

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (4): 74; 78; 88; 94

Mutagenesis-validated functional residues (3):

PositionPhenotype
74–94abolished binding to [2fe-2s] cluster, promoting degradation by afg3l2.
226abolished glutathione import into mitochondria without affecting the levels of nad.
329abolished glutathione import into mitochondria without affecting the levels of nad.

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 172 (showing top): RNGTGGGC_UNKNOWN, GOBP_MODIFIED_AMINO_ACID_TRANSPORT, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GOBP_TETRAPYRROLE_BIOSYNTHETIC_PROCESS, GOBP_MITOCHONDRIAL_TRANSPORT, GOBP_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT, GOBP_RESPONSE_TO_METAL_ION, GOBP_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS, GTGCCTT_MIR506, WEI_MYCN_TARGETS_WITH_E_BOX, GOBP_TETRAPYRROLE_METABOLIC_PROCESS, GOBP_ORGANIC_ANION_TRANSPORT, GOBP_SULFUR_COMPOUND_TRANSPORT, GOBP_PIGMENT_METABOLIC_PROCESS, GOCC_MITOCHONDRIAL_ENVELOPE

GO Biological Process (7): heme biosynthetic process (GO:0006783), cellular response to iron ion (GO:0071281), glutathione import into mitochondrion (GO:0160007), import into the mitochondrion (GO:0170036), transmembrane transport (GO:0055085), cellular response to glutathione (GO:0072753), mitochondrial transmembrane transport (GO:1990542)

GO Molecular Function (4): glutathione transmembrane transporter activity (GO:0034634), metal ion binding (GO:0046872), 2 iron, 2 sulfur cluster binding (GO:0051537), iron-sulfur cluster binding (GO:0051536)

GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
intercellular transport2
glutathione transmembrane transport2
porphyrin-containing compound biosynthetic process1
heme metabolic process1
pigment biosynthetic process1
response to iron ion1
cellular response to metal ion1
mitochondrial transmembrane transport1
transport1
cellular process1
response to glutathione1
cellular response to nitrogen compound1
cellular response to oxygen-containing compound1
mitochondrial transport1
transmembrane transport1
tripeptide transmembrane transporter activity1
modified amino acid transmembrane transporter activity1
sulfur compound transmembrane transporter activity1
cation binding1
iron-sulfur cluster binding1
metal cluster binding1
cytoplasm1
intracellular membrane-bounded organelle1
organelle inner membrane1
mitochondrial membrane1
cellular anatomical structure1

Protein interactions and networks

STRING

942 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SLC25A39RUNDC3AQ59EK9892
SLC25A39GRNP23781672
SLC25A39TMEM14CQ9P0S9636
SLC25A39ISCA1Q9BUE6591
SLC25A39ALAS2P22557573
SLC25A39SLC25A35Q3KQZ1571
SLC25A39TARDBPQ13148549
SLC25A39IBA57Q5T440548
SLC25A39ABCB7O75027525
SLC25A39GATA1P15976491
SLC25A39FECHP22830490
SLC25A39UBBP02248470
SLC25A39SIGMAR1Q99720446
SLC25A39ABCB6Q9NP58428
SLC25A39SFXN1Q9H9B4415

IntAct

7 interactions, top by confidence:

ABTypeScore
HSPD1NUDT19psi-mi:“MI:0914”(association)0.710
IMPDH1BCAT2psi-mi:“MI:0914”(association)0.530
SLC25A39ADORA2Apsi-mi:“MI:0915”(physical association)0.370
IMPDH1MGST3psi-mi:“MI:0914”(association)0.350
lipASLC25A39psi-mi:“MI:0915”(physical association)0.000

BioGRID (12): SLC25A39 (Affinity Capture-RNA), SLC25A39 (Affinity Capture-RNA), SLC25A39 (Affinity Capture-RNA), SLC25A39 (Affinity Capture-MS), SLC25A39 (Two-hybrid), SLC25A39 (Negative Genetic), SLC25A39 (Affinity Capture-RNA), SLC25A39 (Affinity Capture-MS), SLC25A39 (Affinity Capture-MS), SLC25A39 (Affinity Capture-RNA), SLC25A39 (Protein-peptide), SLC25A39 (Affinity Capture-RNA)

ESM2 similar proteins: A0PC02, A1DI57, A2ADF7, A2R5A0, A3KPP4, G3XP90, O95847, P04633, P10861, P12242, P16260, P56500, Q01888, Q08DK7, Q0CEN9, Q17QI7, Q23125, Q29RM1, Q2UCW8, Q3KQZ1, Q3SZK0, Q4V8K4, Q505J6, Q58DS3, Q5HZE0, Q5IS35, Q5NVC1, Q5SWT3, Q5XIF9, Q6AYL0, Q6IS41, Q6J329, Q6PH61, Q6PIV7, Q6Q0C1, Q7SXW0, Q8BL03, Q8C0K5, Q8N8R3, Q9BV35

Diamond homologs: A0A0G2K5L2, A0JN87, A2ADF7, A4QNX2, F1LX07, F1LZW6, F4HT41, G3YFS7, K3VFR5, O18757, O22261, O43772, O75746, O95258, O97562, O97649, P0C546, P0CI40, P23500, P55851, P55916, P56500, P70406, P97521, Q03028, Q08CI8, Q08DK4, Q08DK7, Q12482, Q17QI7, Q19529, Q1ECW7, Q21153, Q27257, Q3SZI5, Q3SZK0, Q505J6, Q54PY7, Q54QN2, Q54RB9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

104 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance81
Likely benign5
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1452 predictions. Top by Δscore:

VariantEffectΔscore
17:44320112:GAAGC:Gacceptor_gain1.0000
17:44320113:AAGC:Aacceptor_gain1.0000
17:44320114:AGC:Aacceptor_gain1.0000
17:44320115:GC:Gacceptor_gain1.0000
17:44320116:CC:Cacceptor_gain1.0000
17:44320117:C:CCacceptor_gain1.0000
17:44320117:CTGCA:Cacceptor_loss1.0000
17:44320120:CAG:Cacceptor_gain1.0000
17:44320121:A:Tacceptor_gain1.0000
17:44320122:G:Cacceptor_gain1.0000
17:44320122:G:GCacceptor_gain1.0000
17:44320192:TGA:Tdonor_loss1.0000
17:44320193:GAC:Gdonor_loss1.0000
17:44320194:A:Cdonor_loss1.0000
17:44320195:CCT:Cdonor_loss1.0000
17:44320207:C:Adonor_gain1.0000
17:44320272:GTTCA:Gacceptor_gain1.0000
17:44320273:TTCA:Tacceptor_gain1.0000
17:44320273:TTCAC:Tacceptor_loss1.0000
17:44320274:TCA:Tacceptor_gain1.0000
17:44320275:CA:Cacceptor_gain1.0000
17:44320275:CAC:Cacceptor_gain1.0000
17:44320276:ACTGC:Aacceptor_loss1.0000
17:44320277:C:CCacceptor_gain1.0000
17:44320277:CTGC:Cacceptor_loss1.0000
17:44320278:T:Aacceptor_loss1.0000
17:44320284:C:CTacceptor_gain1.0000
17:44320349:CCTCA:Cdonor_loss1.0000
17:44320350:CTCAC:Cdonor_loss1.0000
17:44320352:CACCT:Cdonor_loss1.0000

AlphaMissense

2286 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:44320064:G:CS339R0.998
17:44320064:G:TS339R0.998
17:44320066:T:GS339R0.998
17:44320077:G:TA335D0.997
17:44320094:C:AK329N0.997
17:44320094:C:GK329N0.997
17:44321062:G:CF229L0.997
17:44321062:G:TF229L0.997
17:44321064:A:GF229L0.997
17:44320070:C:AM337I0.995
17:44320070:C:GM337I0.995
17:44320070:C:TM337I0.995
17:44320089:G:TA331D0.995
17:44320398:C:AK280N0.995
17:44320398:C:GK280N0.995
17:44323321:C:AK36N0.995
17:44323321:C:GK36N0.995
17:44323501:C:TG21E0.995
17:44323513:G:TA17D0.995
17:44320074:A:TI336N0.994
17:44320432:G:TA269D0.994
17:44323337:G:TP31H0.994
17:44323502:C:GG21R0.994
17:44323502:C:TG21R0.994
17:44320196:C:GG322R0.993
17:44320408:T:AD277V0.993
17:44320638:C:TG262D0.993
17:44321075:C:GR225P0.993
17:44321722:A:GW124R0.993
17:44321722:A:TW124R0.993

dbSNP variants (sampled 300 via entrez): RS1000425732 (17:44321930 C>A,T), RS1000457072 (17:44322117 T>G), RS1000509295 (17:44322232 G>A), RS1000657851 (17:44326694 A>G), RS1001584367 (17:44324147 T>A,C), RS1002154031 (17:44323075 A>G), RS1002188577 (17:44323155 T>A), RS1002752839 (17:44324833 C>T), RS1002829945 (17:44324965 C>G,T), RS1002845031 (17:44325073 T>G), RS1002878881 (17:44323402 C>A,G,T), RS1002967668 (17:44320570 GC>G,GCC), RS1003345954 (17:44320369 A>G), RS1003974412 (17:44320706 C>G), RS1004762385 (17:44323856 G>A,T)

Disease associations

OMIM: gene MIM:610820 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST003991_24Childhood ear infection9.000000e-07

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0007904susceptibility to childhood ear infection measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — SLC25 mitochondrial vitamin and co-factor carriers subfamily

CTD chemical–gene interactions

24 total (human), top 24 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, increases expression4
sodium arseniteincreases expression, affects cotreatment, decreases expression, increases abundance2
Benzo(a)pyrenedecreases expression, increases methylation2
bisphenol Aincreases expression1
beta-lapachoneincreases expression1
cobaltous chloridedecreases expression1
2,3-bis(3’-hydroxybenzyl)butyrolactoneaffects cotreatment, increases expression1
methacrylaldehydeaffects cotreatment, increases oxidation1
N,N,N’,N’-tetrakis(2-pyridylmethyl)ethylenediaminedecreases expression1
perfluorooctane sulfonic acidincreases expression1
MT19c compounddecreases expression1
Acetaminophenincreases expression1
Acroleinaffects cotreatment, increases oxidation1
Arsenicaffects cotreatment, decreases expression, increases abundance1
Atrazineincreases expression1
Coumestrolaffects cotreatment, increases expression1
Ozoneaffects cotreatment, increases oxidation1
Quercetinincreases expression1
Smokedecreases expression1
Thiramdecreases expression1
Tobacco Smoke Pollutionincreases expression1
Tunicamycindecreases expression1
Thapsigargindecreases expression1
Okadaic Acidincreases expression1

Cellosaurus cell lines

6 cell lines: 5 cancer cell line, 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B3H9Abcam HEK293T SLC25A39 KOTransformed cell lineFemale
CVCL_D4K5HCT116-SLC25A39-KO-c7Cancer cell lineMale
CVCL_D4K6HCT116-SLC25A39-KO-c8Cancer cell lineMale
CVCL_TM41HAP1 SLC25A39 (-) 1Cancer cell lineMale
CVCL_TM42HAP1 SLC25A39 (-) 2Cancer cell lineMale
CVCL_TM43HAP1 SLC25A39 (-) 3Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.